Development and validation of the immunosuppressant therapy adherence instrument (ITAS)

Marie Chisholm-Burns, Charles E. Lance, Gail M. Williamson, Laura L. Mulloy

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

A five-item scale was developed that asked respondents to indicate how often they were non-adherent to immunosuppressant therapy (IST) given a particular circumstance. Two hundred and twenty-two recipients completed the instrument. Validity of the scale was assessed by correlating composite item scores with refill record adherence rates (RRARs), serum immunosuppressant (IS) concentrations, graft rejection, and increased serum creatinine (SCr) levels. One scale item was deleted due to lack of response variability. Cronbach's alpha coefficient for the four-item scale was 0.81, demonstrating that the scale has acceptable reliability. All items loaded on a single principal component, suggesting that the scale measures a single adherence construct, which accounted for 64% of the scale items' variance. The four-item scale, adherence measured by IS RRARs, and "target" IS serum concentrations had positive correlations (p < 0.01). Item scores were shown to be negatively related to rejection occurrence and increased SCr (p < 0.05). The immunosuppressant therapy adherence scale is the first published, valid and reliable instrument that measures recipients IST adherence.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalPatient Education and Counseling
Volume59
Issue number1
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Immunosuppressive Agents
Serum
Creatinine
Therapeutics
Graft Rejection

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Development and validation of the immunosuppressant therapy adherence instrument (ITAS). / Chisholm-Burns, Marie; Lance, Charles E.; Williamson, Gail M.; Mulloy, Laura L.

In: Patient Education and Counseling, Vol. 59, No. 1, 01.10.2005, p. 13-20.

Research output: Contribution to journalArticle

Chisholm-Burns, Marie ; Lance, Charles E. ; Williamson, Gail M. ; Mulloy, Laura L. / Development and validation of the immunosuppressant therapy adherence instrument (ITAS). In: Patient Education and Counseling. 2005 ; Vol. 59, No. 1. pp. 13-20.
@article{929e2762c46a4130aae5a69810348f14,
title = "Development and validation of the immunosuppressant therapy adherence instrument (ITAS)",
abstract = "A five-item scale was developed that asked respondents to indicate how often they were non-adherent to immunosuppressant therapy (IST) given a particular circumstance. Two hundred and twenty-two recipients completed the instrument. Validity of the scale was assessed by correlating composite item scores with refill record adherence rates (RRARs), serum immunosuppressant (IS) concentrations, graft rejection, and increased serum creatinine (SCr) levels. One scale item was deleted due to lack of response variability. Cronbach's alpha coefficient for the four-item scale was 0.81, demonstrating that the scale has acceptable reliability. All items loaded on a single principal component, suggesting that the scale measures a single adherence construct, which accounted for 64{\%} of the scale items' variance. The four-item scale, adherence measured by IS RRARs, and {"}target{"} IS serum concentrations had positive correlations (p < 0.01). Item scores were shown to be negatively related to rejection occurrence and increased SCr (p < 0.05). The immunosuppressant therapy adherence scale is the first published, valid and reliable instrument that measures recipients IST adherence.",
author = "Marie Chisholm-Burns and Lance, {Charles E.} and Williamson, {Gail M.} and Mulloy, {Laura L.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.pec.2004.09.003",
language = "English (US)",
volume = "59",
pages = "13--20",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Development and validation of the immunosuppressant therapy adherence instrument (ITAS)

AU - Chisholm-Burns, Marie

AU - Lance, Charles E.

AU - Williamson, Gail M.

AU - Mulloy, Laura L.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - A five-item scale was developed that asked respondents to indicate how often they were non-adherent to immunosuppressant therapy (IST) given a particular circumstance. Two hundred and twenty-two recipients completed the instrument. Validity of the scale was assessed by correlating composite item scores with refill record adherence rates (RRARs), serum immunosuppressant (IS) concentrations, graft rejection, and increased serum creatinine (SCr) levels. One scale item was deleted due to lack of response variability. Cronbach's alpha coefficient for the four-item scale was 0.81, demonstrating that the scale has acceptable reliability. All items loaded on a single principal component, suggesting that the scale measures a single adherence construct, which accounted for 64% of the scale items' variance. The four-item scale, adherence measured by IS RRARs, and "target" IS serum concentrations had positive correlations (p < 0.01). Item scores were shown to be negatively related to rejection occurrence and increased SCr (p < 0.05). The immunosuppressant therapy adherence scale is the first published, valid and reliable instrument that measures recipients IST adherence.

AB - A five-item scale was developed that asked respondents to indicate how often they were non-adherent to immunosuppressant therapy (IST) given a particular circumstance. Two hundred and twenty-two recipients completed the instrument. Validity of the scale was assessed by correlating composite item scores with refill record adherence rates (RRARs), serum immunosuppressant (IS) concentrations, graft rejection, and increased serum creatinine (SCr) levels. One scale item was deleted due to lack of response variability. Cronbach's alpha coefficient for the four-item scale was 0.81, demonstrating that the scale has acceptable reliability. All items loaded on a single principal component, suggesting that the scale measures a single adherence construct, which accounted for 64% of the scale items' variance. The four-item scale, adherence measured by IS RRARs, and "target" IS serum concentrations had positive correlations (p < 0.01). Item scores were shown to be negatively related to rejection occurrence and increased SCr (p < 0.05). The immunosuppressant therapy adherence scale is the first published, valid and reliable instrument that measures recipients IST adherence.

UR - http://www.scopus.com/inward/record.url?scp=25844480596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844480596&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2004.09.003

DO - 10.1016/j.pec.2004.09.003

M3 - Article

VL - 59

SP - 13

EP - 20

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

IS - 1

ER -